Sunshine Biopharma (SBFMW) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Sunshine Biopharma (SBFMW) over the last 14 years, with Q3 2025 value amounting to -$9.3 million.
- Sunshine Biopharma's Enterprise Value rose 2375.93% to -$9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.3 million, marking a year-over-year increase of 2375.93%. This contributed to the annual value of -$9.7 million for FY2024, which is 4054.55% up from last year.
- Latest data reveals that Sunshine Biopharma reported Enterprise Value of -$9.3 million as of Q3 2025, which was up 2375.93% from -$10.3 million recorded in Q2 2025.
- Sunshine Biopharma's Enterprise Value's 5-year high stood at -$1.7 million during Q2 2021, with a 5-year trough of -$41.7 million in Q2 2022.
- Moreover, its 5-year median value for Enterprise Value was -$12.2 million (2024), whereas its average is -$14.6 million.
- In the last 5 years, Sunshine Biopharma's Enterprise Value plummeted by 970642.46% in 2021 and then soared by 5353.92% in 2023.
- Sunshine Biopharma's Enterprise Value (Quarter) stood at -$2.1 million in 2021, then plummeted by 963.27% to -$21.8 million in 2022, then grew by 25.35% to -$16.3 million in 2023, then surged by 40.55% to -$9.7 million in 2024, then grew by 3.92% to -$9.3 million in 2025.
- Its Enterprise Value was -$9.3 million in Q3 2025, compared to -$10.3 million in Q2 2025 and -$8.2 million in Q1 2025.